Pharmacist Allegedly used 108 Ambulance service to buy drugs

Punjab’s government 108 Ambulance service caught with intoxicating pills and drugs by the  sarpanch of Talwandi village. Talwandi village is infamous for drugs and intoxicating material supply.

Pharmacist cleverly make use of 108 service to purchase drugs and intoxicating pills. Pharmacist came to the village in the Ambulance with a pretext to picking up a patient but actually came to buy the strip of a banned pharmaceutical drug.

Pharmacist has been identified as Amritpal Singh of Bahini Sahib village in Tarn Taran. Police inspected ambulance driver Sukhraj Singh of Gurdaspur,but not found anything incriminating. Police have taken him into custody to investigate why did he use the ambulance to Ludhiana from Phillaur. 

Talwandi Village Sarpanch Manjit Singh informed the police about him and they have been detained at Salem Tabri police station. Manjit told the police that he noticed the Ambulance coming to the village often for over a year. And they found definitely there will be any suspicious activity going on. And to clear their thoughts, this time, they stopped the ambulance and found the pharmacist consuming drugs in the Ambulance.

Gurpreet Singh Sikand, additional deputy commissioner of Ludhiana police said that their preliminary enquiry had revealed that the pharmacist used Ambulance to procure drugs form a resident of Talwandi. He always comes to the village in the ambulance to buy drugs and police investigating that has he used it for smuggling or not. Gurpreet also added that their team were raiding the village to nab the drug supplier and lodged an FIR against the pharmacist.

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March